Veraxa Biotech AG
Ownership
Ownership Structure
Who owns Veraxa Biotech AG (VRXA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 2.7% of the shares are freely tradable; institutional investors hold 8.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Picton Mahoney Asset Management | 0.12 | 175,000 | +0.0 | 06/30/2026 |
| UBS Group AG | 0.11 | 157,237 | +0.0 | 06/30/2026 |
| Geode Capital Management, LLC | 0.08 | 119,767 | +0.0 | 06/30/2026 |
| HRT FINANCIAL LLC | 0.01 | 18,874 | +0.0 | 06/30/2026 |
| Susquehanna International Group, LLP | 0.01 | 10,833 | +0.0 | 06/30/2026 |
| Wolverine Asset Management LLC | 0.00 | 1,748 | +0.0 | 06/30/2026 |
| JPMorgan Chase & Co | 0.00 | 396 | +0.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Nasdaq Composite Index | 0.04 | 57,820 | -32.8 | 08/31/2026 |
| Fidelity Nasdaq Composite ETF | 0.02 | 33,992 | +0.0 | 10/30/2026 |
| JNL Multi-Manager Alternative A | 0.01 | 7,745 | +0.0 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Baumann Oliver Rolf | Director | 5,773,618 | 6,350,980 $ | Aug 27, 2026 | indirect |
| Ziegler Christoph Samuel | Director | 37,932 | 41,725 $ | Oct 20, 2026 | direct |
| Gruninger Marc | Director | 10,000 | 11,000 $ | Oct 28, 2026 | direct |
| Antz Christoph Rudiger | Chief Executive Officer | 5,000 | 5,500 $ | Aug 27, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | Gruninger Marc | Director | Buy | 9,133 | 1.00 | 9,133 |
| Oct 27, 2026 | Gruninger Marc | Director | Buy | 867 | 0.98 | 850 |
| Oct 20, 2026 | Ziegler Christoph Samuel | Director | Buy | 30,000 | 1.09 | 32,700 |
| Aug 27, 2026 | Baumann Oliver Rolf | Director | Buy | 50,000 | 1.50 | 75,000 |
| Aug 27, 2026 | Antz Christoph Rudiger | Chief Executive Officer | Buy | 5,000 | 1.53 | 7,650 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.